Contrast-Enhanced and Time-of-Flight MRA at 3T Compared with DSA for the Follow-Up of Intracranial Aneurysms Treated

C Timsit1, S Soize1, A Benaissa1

  • 1From the Department of Neuroradiology (C.T., S.S., A.B., L.P.), Hôpital Maison Blanche, Université de Champagne-Ardenne, Reims, France.

Abstract

Insights

Magnetic Resonance Angiography (MRA) at 3T is a useful screening tool for Woven EndoBridge (WEB) device-treated aneurysms. However, Digital Subtraction Angiography (DSA) remains the gold standard for definitive follow-up due to MRA

Area of Science:

  • Neuroradiology
  • Medical Imaging
  • Interventional Neurology

Background:

  • Intracranial aneurysms treated with the Woven EndoBridge (WEB) device require effective imaging follow-up.
  • 3T Magnetic Resonance Angiography (MRA) has not been previously evaluated for WEB device treatment follow-up.

Purpose of the Study:

  • To assess the diagnostic accuracy of 3T 3D-time-of-flight MRA (3D-TOF-MRA) and contrast-enhanced MRA (CE-MRA) compared to Digital Subtraction Angiography (DSA).
  • To evaluate MRA's effectiveness in the follow-up of intracranial aneurysms treated with the WEB system.

Main Methods:

  • Retrospective analysis of 26 patients treated with WEB devices and followed for ≥6 months.
  • Comparison of 3T 3D-TOF-MRA and CE-MRA against DSA (criterion standard) for aneurysm occlusion assessment.
  • Evaluation of interobserver and intermodality agreement using linear weighted kappa (κ) and calculation of MRA test characteristics.

Main Results:

  • Interobserver reproducibility was good for DSA (κ=0.71) and CE-MRA (κ=0.65), moderate for 3D-TOF-MRA (κ=0.47).
  • Intermodality agreement with DSA was fair for both MRA techniques (κ=0.36) in evaluating total occlusion.
  • For aneurysm remnant detection (15% prevalence), MRA showed low sensitivity (25%) but high specificity (100%), with excellent positive (100%) and negative (88%) predictive values.

Conclusions:

  • 3T MRA techniques demonstrate acceptable interobserver reproducibility and predictive values for WEB-treated aneurysms.
  • Low sensitivity of MRA for detecting aneurysm remnants suggests it is a useful screening tool.
  • DSA remains the criterion standard for definitive follow-up of WEB-treated aneurysms, similar to other endovascular devices.